Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois. more
Time Frame | BAX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -5.67% | -2.12% | 0.77% |
1-Month Return | -11.94% | -2.54% | 2.65% |
3-Month Return | -18.38% | -6.28% | 12.3% |
6-Month Return | -4.56% | -1.36% | 13.48% |
1-Year Return | -11.49% | 9.29% | 33.47% |
3-Year Return | -59.87% | 10.05% | 32.22% |
5-Year Return | -61.77% | 43.69% | 92.85% |
10-Year Return | -21.03% | 103.1% | 194.31% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 11.36B | 11.67B | 12.78B | 15.11B | 14.81B | [{"date":"2019-12-31","value":75.18,"profit":true},{"date":"2020-12-31","value":77.24,"profit":true},{"date":"2021-12-31","value":84.59,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.01,"profit":true}] |
Cost of Revenue | 6.60B | 7.09B | 7.68B | 9.72B | 9.84B | [{"date":"2019-12-31","value":67.1,"profit":true},{"date":"2020-12-31","value":72.03,"profit":true},{"date":"2021-12-31","value":78.05,"profit":true},{"date":"2022-12-31","value":98.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 4.76B | 4.59B | 5.11B | 5.40B | 4.97B | [{"date":"2019-12-31","value":88.22,"profit":true},{"date":"2020-12-31","value":84.99,"profit":true},{"date":"2021-12-31","value":94.59,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.18,"profit":true}] |
Gross Margin | 41.90% | 39.30% | 39.93% | 35.71% | 33.59% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":93.78,"profit":true},{"date":"2021-12-31","value":95.3,"profit":true},{"date":"2022-12-31","value":85.22,"profit":true},{"date":"2023-12-31","value":80.15,"profit":true}] |
Operating Expenses | 3.88B | 2.97B | 3.40B | 4.53B | 4.58B | [{"date":"2019-12-31","value":84.73,"profit":true},{"date":"2020-12-31","value":64.8,"profit":true},{"date":"2021-12-31","value":74.05,"profit":true},{"date":"2022-12-31","value":98.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 976.00M | 603.00M | 779.00M | (549.00M) | 390.00M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":61.78,"profit":true},{"date":"2021-12-31","value":79.82,"profit":true},{"date":"2022-12-31","value":-56.25,"profit":false},{"date":"2023-12-31","value":39.96,"profit":true}] |
Total Non-Operating Income/Expense | (77.00M) | 555.00M | (65.00M) | (802.00M) | (935.00M) | [{"date":"2019-12-31","value":-13.87,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-11.71,"profit":false},{"date":"2022-12-31","value":-144.5,"profit":false},{"date":"2023-12-31","value":-168.47,"profit":false}] |
Pre-Tax Income | 970.00M | 1.29B | 1.48B | (2.35B) | (103.00M) | [{"date":"2019-12-31","value":65.67,"profit":true},{"date":"2020-12-31","value":87.47,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-159.31,"profit":false},{"date":"2023-12-31","value":-6.97,"profit":false}] |
Income Taxes | (41.00M) | 182.00M | 182.00M | 68.00M | (34.00M) | [{"date":"2019-12-31","value":-22.53,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":37.36,"profit":true},{"date":"2023-12-31","value":-18.68,"profit":false}] |
Income After Taxes | 1.01B | 1.11B | 1.29B | (2.42B) | (69.00M) | [{"date":"2019-12-31","value":78.07,"profit":true},{"date":"2020-12-31","value":85.71,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-186.95,"profit":false},{"date":"2023-12-31","value":-5.33,"profit":false}] |
Income From Continuous Operations | 1.01B | 1.11B | 1.29B | (2.42B) | (69.00M) | [{"date":"2019-12-31","value":78.07,"profit":true},{"date":"2020-12-31","value":85.71,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-186.95,"profit":false},{"date":"2023-12-31","value":-5.33,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 1.00B | 1.10B | 1.28B | (2.42B) | 2.66B | [{"date":"2019-12-31","value":37.69,"profit":true},{"date":"2020-12-31","value":41.49,"profit":true},{"date":"2021-12-31","value":48.34,"profit":true},{"date":"2022-12-31","value":-91.15,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 3.36 | 3.09 | 3.62 | 3.50 | 2.70 | [{"date":"2019-12-31","value":92.82,"profit":true},{"date":"2020-12-31","value":85.36,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.69,"profit":true},{"date":"2023-12-31","value":74.59,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
BAX | |
---|---|
Cash Ratio | 0.23 |
Current Ratio | 1.43 |
Quick Ratio | 1.09 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BAX | |
---|---|
ROA (LTM) | 3.16% |
ROE (LTM) | 1.63% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BAX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.70 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.30 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BAX | |
---|---|
Trailing PE | 127.60 |
Forward PE | 9.81 |
P/S (TTM) | 1.08 |
P/B | 2.07 |
Price/FCF | 71 |
EV/R | 1.86 |
EV/Ebitda | 15.34 |
PEG | 1.70 |
Baxter International Inc (BAX) share price today is $31.8
Yes, Indians can buy shares of Baxter International Inc (BAX) on Vested. To buy Baxter International Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BAX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Baxter International Inc (BAX) via the Vested app. You can start investing in Baxter International Inc (BAX) with a minimum investment of $1.
You can invest in shares of Baxter International Inc (BAX) via Vested in three simple steps:
The 52-week high price of Baxter International Inc (BAX) is $43.07. The 52-week low price of Baxter International Inc (BAX) is $31.44.
The price-to-earnings (P/E) ratio of Baxter International Inc (BAX) is 127.6
The price-to-book (P/B) ratio of Baxter International Inc (BAX) is 2.07
The dividend yield of Baxter International Inc (BAX) is 2.13%
The market capitalization of Baxter International Inc (BAX) is $16.29B
The stock symbol (or ticker) of Baxter International Inc is BAX